41314 Federal Register / Vol. 87, No. 132 / Tuesday, July 12, 2022 / Notices 

ME DEP’s request to revise/modify its 

EPA-authorized programs and, based on 

this review, EPA determined that the 

application met the standards for 

approval of authorized program 

revisions/modifications set out in 40 

CFR part 3, subpart D. In accordance 

with 40 CFR 3.1000(d), this notice of 

EPA’s decision to approve ME DEP’s 

request to revise/modify its following 

EPA-authorized programs to allow 

electronic reporting under 40 CFR is 

being published in the Federal Register: 

Part 123: EPA-Administered Permit 

Programs: the National Pollutant 

Discharge Elimination System (NPDES) 

Reporting under 40 CFR parts 122 and 

125 

Part 403: General Pretreatment 

Regulations for Existing and New 

Sources of Pollution Reporting under 40 

CFR part 403 

ME DEP was notified of EPA’s 

determination to approve its application 

with respect to the authorized programs 

listed above. 

Dated: July 6, 2022. 

Jennifer Campbell, 

Director, Office of Information Management. 

[FR Doc. 2022–14754 Filed 7–11–22; 8:45 am] 

BILLING CODE 6560–50–P 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington, DC 20551–0001, not later 

than August 11, 2022. 

A. Federal Reserve Bank of Cleveland 

(Bryan S. Huddleston, Vice President) 

1455 East Sixth Street, Cleveland, Ohio 

44101–2566, or electronically to 

Comments.applications@clev.frb.org: 

1. F.N.B. Corporation, Pittsburgh, 

Pennsylvania; to acquire UB Bancorp, 

and thereby indirectly acquire Union 

Bank, both of Greenville, North 

Carolina. 

B. Federal Reserve Bank of Dallas 

(Karen Smith, Director, Applications) 

2200 North Pearl Street, Dallas, Texas 

75201–2272: 

1. Global One Bancshares, Inc., 

Carrollton, Texas; to become a bank 

holding company by acquiring Chappell 

Hill Bank, Chappell Hill, Texas. 

Board of Governors of the Federal Reserve 

System. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2022–14837 Filed 7–11–22; 8:45 am] 

BILLING CODE P 

GENERAL SERVICES 

ADMINISTRATION 

Notice–ID–2022–0X; Docket No. 2022– 

000X; Sequence No. XX] 

Privacy Act of 1974; System of 

Records 

AGENCY: General Services 

Administration, (GSA). 

ACTION: Notice of a Modified System of 

Records. 

SUMMARY: GSA proposes to revise a 

system of records subject to the Privacy 

Act of 1974, as amended. The system 

will provide for the collection of 

information to track and manage the Art 

in Architecture program, the National 

Artist Registry, and the fine arts 

collection. 

DATES: Applicable: August 11, 2022. 

ADDRESSES: Submit comments 

identified by ‘‘Notice-ID–2022–0X, 

Modify System of Records’’ via http://

www.regulations.gov. Search 

regulations.gov for Notice–ID–2022–0X, 

Modified System of Records Notice. 

Select the link ‘‘Comment’’ that 

corresponds with ‘‘Notice-ID–2022–0X, 

Modified System of Records Notice.’’ 

Follow the instructions provided on the 

screen. Please include your name, 

company name (if any), and ‘‘Notice– 

ID–2022–0X, Modified System of 

Records Notice’’ on your attached 

document. If your comment cannot be 

submitted using regulations.gov, call or 

email the points of contact in the FOR

FURTHER INFORMATION CONTACT section of 

this document for alternate instructions. 

FOR FURTHER INFORMATION CONTACT: Call 

or email the GSA Chief Privacy Officer: 

telephone 202–322–8246; email 

gsa.privacyact@gsa.gov. 

SUPPLEMENTARY INFORMATION: GSA 

proposes to modify a system of records 

subject to the Privacy Act of 1974, 5 

U.S.C. 552a. The modified system will 

continue to provide for the collection of 

information to track and manage the Art 

in Architecture program and now 

includes optional data elements within 

the ‘‘categories of records’’, clarifies one 

routine use and updates the records 

retention description to enhance 

collection management. 

SYSTEM NAME AND NUMBER: 

The Museum System (TMS) GSA/ 

PBS–7. 

SECURITY CLASSIFICATION: 

Unclassified. 

SYSTEM LOCATION: 

The system is maintained for GSA 

under contract, and the records are 

maintained in electronic form. The 

system and records are located at the 

vendor location in RTP Data Center 

(GSA Building Code NC9999), 109 T.W. 

Alexander Drive, Research Triangle 

Park, NC 27711. 

SYSTEM MANAGER: 

General Services Administration, 

Attn: Jennifer Gibson, Director, Center 

for Fine Arts, 1800 F Street NW, 

Washington, DC 20405; email 

jennifer.gibson@gsa.gov. 

* * * * * 

CATEGORIES OF RECORDS IN THE SYSTEM: 

The system contains information 

needed for managing the Art in 

Architecture, Fine Arts, and the Design 

Excellence Peer programs, which 

includes access to information on artists 

represented in the fine arts collection, 

artists in the National Registry, and 

participants in the Design Excellence 

Peer program. Records may include but 

are not limited to: (1) Biographical data 

such as name, birth date, and 

educational level; and (2) contact 

information such as telephone number, 

street address and email address; and (3) 

optional demographic information 

including gender, race and ethnicity. 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 132 / Tuesday, July 12, 2022 / Notices 41315 

ROUTINE USES OF RECORDS MAINTAINED IN THE

SYSTEM, INCLUDING CATEGORIES OF USERS AND

PURPOSES OF SUCH USES: 

h. In consultation with the artist or 

the artist’s representatives and 

consistent with professional practices in 

other arts institutions, nationality, city, 

state, country and year of birth may be 

disclosed to the public when relevant to 

an artist’s work. 

POLICIES AND PRACTICES FOR RETENTION AND

DISPOSAL OF RECORDS: 

121.1/040 Significant Art Inventory 

Records. 

This series contains records used in 

identifying items within the building 

that are removable or replaceable, or 

have a significant historical and/or 

architectural value. For art associated 

with a building (such as statuary, 

paintings, and architectural features), 

records such as inventories, case files, 

art maintenance records, art appraisals 

and art restoration documents and 

related materials are included. 

Retention: Permanent. Cut off at the 

end of the fiscal year when the case file 

is closed, the artifact is destroyed, 

transferred, or otherwise deaccessioned. Transfer to NARA 15 years 

after cutoff. 

Legal Authority: DAA–0121–2015– 

0001–0007 (121.1/040). 121.1/041 

Routine Equipment and Art Inventory 

Records. This series contains records 

used in identifying equipment and 

items within the building that are 

removable or replaceable. Included are 

inventories of heating, electrical, 

plumbing, and air handling equipment, 

vertical transportation equipment and 

records related to recording the 

condition, maintenance, and associated 

schedules, documentation, and 

schematics for that equipment. For 

managing statuary, paintings, and 

architectural features associated with a 

building, records include routine 

correspondence and maintenance 

reports, exhibition and curated 

collections management documents, 

proposal submissions, and other records 

not filed under 121.1/040—Significant 

Art Inventory Records. 

Retention: Temporary. Cut off at the 

end of the fiscal year when art or 

equipment has been deaccessioned, 

obsolete, or superseded, a case file is 

closed, or when related documents 

expire. Destroy 5 fiscal years after 

cutoff. 

Legal Authority: DAA–0121–2015– 

0001–0008 (121.1/041). 

* * * * * 

HISTORY: 

86 FR 46849. 

Dated: June 29, 2022. 

Richard Speidel, 

Chief Privacy Officer, Office of the Deputy 

Chief Information Officer, General Services 

Administration. 

[FR Doc. 2022–14827 Filed 7–11–22; 8:45 am] 

BILLING CODE 6820–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Supplemental Evidence and Data 

Request on Radiation Therapy for 

Bone Metastases 

AGENCY: Agency for Healthcare Research 

and Quality (AHRQ), HHS. 

ACTION: Request for Supplemental 

Evidence and Data Submissions. 

SUMMARY: The Agency for Healthcare 

Research and Quality (AHRQ) is seeking 

scientific information submissions from 

the public. Scientific information is 

being solicited to inform our review on 

Radiation Therapy for Bone Metastases, 

which is currently being conducted by 

the AHRQ’s Evidence-based Practice 

Centers (EPC) Program. Access to 

published and unpublished pertinent 

scientific information will improve the 

quality of this review. 

DATES: Submission Deadline on or 

before August 11, 2022. 

ADDRESSES: 

Email submissions: epc@

ahrq.hhs.gov. 

Print submissions: 

Mailing Address: Center for Evidence 

and Practice Improvement, Agency for 

Healthcare Research and Quality, 

ATTN: EPC SEADs Coordinator, 5600 

Fishers Lane, Mail Stop 06E53A, 

Rockville, MD 20857 

Shipping Address (FedEx, UPS, etc.): 

Center for Evidence and Practice 

Improvement, Agency for Healthcare 

Research and Quality, ATTN: EPC 

SEADs Coordinator, 5600 Fishers 

Lane, Mail Stop 06E77D, Rockville, 

MD 20857 

FOR FURTHER INFORMATION CONTACT: 

Jenae Benns, Telephone: 301–427–1496 

or Email: epc@ahrq.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Agency for Healthcare Research and 

Quality has commissioned the 

Evidence-based Practice Center (EPC) 

Program to complete a review of the 

evidence for Radiation Therapy for 

Bone Metastases. AHRQ is conducting 

this systematic review pursuant to 

Section 902 of the Public Health Service 

Act, 42 U.S.C. 299a. 

The EPC Program is dedicated to 

identifying as many studies as possible 

that are relevant to the questions for 

each of its reviews. In order to do so, we 

are supplementing the usual manual 

and electronic database searches of the 

literature by requesting information 

from the public (e.g., details of studies 

conducted). We are looking for studies 

that report on Radiation Therapy for 

Bone Metastases, including those that 

describe adverse events. The entire 

research protocol is available online at: 

https://effectivehealthcare.ahrq.gov/ 

products/radiation-therapy-bonemetastases/protocol. 

This is to notify the public that the 

EPC Program would find the following 

information on Radiation Therapy for 

Bone Metastases helpful: 

D A list of completed studies that 

your organization has sponsored for this 

indication. In the list, please indicate 

whether results are available on 

ClinicalTrials.gov along with the 

ClinicalTrials.gov trial number. 

D For completed studies that do not 

have results on ClinicalTrials.gov, a 

summary, including the following 

elements: study number, study period, 

design, methodology, indication and 

diagnosis, proper use instructions, 

inclusion and exclusion criteria, 

primary and secondary outcomes, 

baseline characteristics, number of 

patients screened/eligible/enrolled/lost 

to follow-up/withdrawn/analyzed, 

effectiveness/efficacy, and safety results. 

D A list of ongoing studies that your 

organization has sponsored for this 

indication. In the list, please provide the 

ClinicalTrials.gov trial number or, if the 

trial is not registered, the protocol for 

the study including a study number, the 

study period, design, methodology, 

indication and diagnosis, proper use 

instructions, inclusion and exclusion 

criteria, and primary and secondary 

outcomes. 

D Description of whether the above 

studies constitute ALL Phase II and 

above clinical trials sponsored by your 

organization for this indication and an 

index outlining the relevant information 

in each submitted file. 

Your contribution is very beneficial to 

the Program. Materials submitted must 

be publicly available or able to be made 

public. Materials that are considered 

confidential; marketing materials; study 

types not included in the review; or 

information on indications not included 

in the review cannot be used by the EPC 

Program. This is a voluntary request for 

information, and all costs for complying 

with this request must be borne by the 

submitter. 

The draft of this review will be posted 

on AHRQ’s EPC Program website and 


jspears on DSK121TN23PROD with NOTICES1